Sep 2012 to 2000 Portfolio Manager Assistant InternshipHina Investment Group
Jun 2012 to Aug 2012 Private Equity Analyst InternshipMerchants Bank Mutual Fund Shenzhen, CN Jun 2011 to Aug 2011 Macroeconomic Analyst Assistant InternshipPrime Armlet Inc San Mateo, CA Jun 2010 to Aug 2010 Financial AnalystMetawise Group Inc Foster City, CA 2008 to 2010 Sales Representative Internship
Education:
University of California Davis, CA 2008 to 2012 Bachelor of Science in Managerial Economics
Bioacoustics Research Laboratory in University of Illinois at Urbana-Champaign
2010 to 2000 Work as Research AssistantBioacoustics Research Laboratory in University of Illinois at Urbana-Champaign Palo Alto, CA May 2011 to Aug 2011 Data Mining Research InternIntel, SSG Group
Jul 2005 to Sep 2005 Software Engineer InternEricsson Inc., Shanghai
Nov 2004 to Mar 2005 Software Engineer InternSanShang Medical Software
Jul 2003 to Aug 2003 Software Engineer Intern
Education:
University of Illinois Urbana-Champaign, IL Mar 2012 Master in StatisticsZhejiang University Jun 2007 Master of Science in Computer ScienceShanghai JiaoTong university Apr 2000 to Jun 2005 Bachelor of science in Computer ScienceShanghai JiaoTong University
Kuo-Shih Liu - Milpitas CA Ramana Veerasingam - Scott Valley CA Zhi Xu - Albany CA Ping Xu - Fremont CA Mario Dave Silvetti - Morgan Hill CA Gang Chen - Mountain View CA
Assignee:
Applied Materials, Inc. - Santa Clara CA
International Classification:
C23C 1600
US Classification:
118723E, 118723 R
Abstract:
An appparatus for confining plasma within a process zone of a substrate processing chamber. In one aspect, an apparatus comprises an annular member having an upper mounting surface, an inner confinement wall, and an outer confinement wall. The apparatus is disposed on or otherwise connected to a gas distribution assembly of the processing chamber to prevent plasma edge effects on the surface of a substrate. The apparatus provides a plasma choke aperture that reduces the volume of the process zone around the periphery of the substrate thereby eliminating uneven deposition of material around the edge of the substrate.
Linda Masat - Oakland CA, US Mary Haak-Frendscho - Newark CA, US Gang Chen - San Diego CA, US Arnold Horwitz - San Leandro CA, US Marina Roell - Concord CA, US
Assignee:
XOMA Technology, Ltd. - Berkely CA
International Classification:
C07K 16/24 A61K 39/395
US Classification:
424 852, 5303871, 5303881
Abstract:
An IL-1β binding antibody or IL-1β binding fragment thereof comprising the amino acid sequence of SEQ ID NO: 2, and related nucleic acids, vectors, cells, and compositions, as well as method of using same to treat or prevent a disease, and a method of preparing an affinity matured IL-1β binding polypeptide. IL-1β binding antibodies or IL-1β binding fragments thereof are provided which have desirable affinity and potency.
Method Of Treating Or Preventing An Il-1 Related Disease Or Condition
Linda Masat - Oakland CA, US Mary Haak-Frendscho - Newark CA, US Gang Chen - San Diego CA, US Arnold Horwitz - San Leandro CA, US Marina Roell - Concord CA, US
Assignee:
XOMA Technology Ltd. - Berkeley CA
International Classification:
C12N 5/10 C12N 15/13 C12N 15/63
US Classification:
536 2353, 435325, 4352523, 4353201
Abstract:
Methods of treating or preventing an IL-1 related disease or condition in a mammal comprising administering an effective amount of an IL-1β binding antibody or IL-1β binding fragment thereof. An IL-1β binding antibody or IL-1β binding fragment thereof is provided comprising the amino acid sequence of SEQ ID NO:28, and related nucleic acids, vectors, cells, and compositions, and a method of preparing an affinity matured IL-1β binding polypeptide is provided. IL-1β binding antibodies or IL-1β binding fragments thereof are provided which have desirable affinity and potency.
Method Of Treating An Il-1 Related Inflammatory Disease Or Condition
Linda Masat - Oakland CA, US Mary Haak-Frendscho - Newark CA, US Gang Chen - San Diego CA, US Arnold Horwitz - San Leandro CA, US Marina Roell - Concord CA, US
Assignee:
XOMA Technology Ltd. - Berkeley CA
International Classification:
A61K 39/395
US Classification:
4241411, 4241451, 4241391
Abstract:
Methods of treating or preventing an IL-1 related disease or condition in a mammal comprising administering an effective amount of an IL-1β binding antibody or IL-1β binding fragment thereof. An IL-1β binding antibody or IL-1β binding fragment thereof is provided comprising the amino acid sequence of SEQ ID NO:28, and related nucleic acids, vectors, cells, and compositions, and a method of preparing an affinity matured IL-1β binding polypeptide is provided. IL-1β binding antibodies or IL-1β binding fragments thereof are provided which have desirable affinity and potency.
Linda Masat - Walnut Creek CA, US Mary Haak-Frendscho - Newark CA, US Arnold H. Horwitz - San Leandro CA, US Gang Chen - San Diego CA, US Marina Roell - Concord CA, US
Assignee:
Xoma Technology Ltd. - Berkeley CA
International Classification:
C07K 16/24 A61K 39/395
US Classification:
424 852, 5303871, 5303881
Abstract:
An IL-1β binding antibody or IL-1β binding fragment thereof comprising the amino acid sequence of SEQ ID NO: 8 and SEQ ID NO: 9, and related nucleic acids, vectors, cells, and compositions, as well as method of using same to treat or prevent a disease. IL-1β binding antibodies or IL-1β binding fragments thereof are provided which have desirable affinity and potency.
Il-1Β Binding Antibodies And Binding Fragments Thereof
Linda Masat - Walnut Creek CA, US Mary Haak-Frendscho - Newark CA, US Arnold H. Horwitz - San Leandro CA, US Gang Chen - San Diego CA, US Marina Roell - Concord CA, US
Assignee:
XOMA Technology Ltd. - Berkeley CA
International Classification:
C07K 16/24 A61K 39/395
US Classification:
424 852, 5303871, 5303881
Abstract:
An IL-1β binding antibody or IL-1β binding fragment thereof comprising the amino acid sequence of SEQ ID NO: 26 and SEQ ID NO: 11, and related nucleic acids, vectors, cells, and compositions, as well as method of using same to treat or prevent a disease. IL-1β binding antibodies or IL-1β binding fragments thereof are provided which have desirable affinity and potency.
Method Of Treating An Il-1 Related Autoimmune Disease Or Condition
Linda Masat - Walnut Creek CA, US Mary Haak-Frendscho - Newark CA, US Arnold H. Horwitz - San Leandro CA, US Gang Chen - San Diego CA, US Marina Roell - Concord CA, US
Assignee:
Xoma Technology Ltd. - Berkeley CA
International Classification:
A61K 39/395
US Classification:
4241451, 4241301, 4241391, 4241411, 514885
Abstract:
Methods of treating or preventing an IL-1 related disease or condition in a mammal comprising administering an effective amount of an IL-1β binding antibody or IL-1β binding fragment thereof. An IL-1β binding antibody or IL-1β binding fragment thereof is provided comprising the amino acid sequence of SEQ ID NO: 15 and SEQ ID NO: 11, and related nucleic acids, vectors, cells, and compositions, and a method of preparing an affinity matured IL-1β binding polypeptide. IL-1β binding antibodies or IL-1β binding fragments thereof are provided which have desirable affinity and potency.
Linda Masat - Walnut Creek CA, US Mary Haak-Frendscho - Newark CA, US Arnold H. Horwitz - San Leandro CA, US Gang Chen - San Diego CA, US Marina Roell - Concord CA, US
Assignee:
Xoma Technology Ltd. - Berkeley CA
International Classification:
A61K 39/395
US Classification:
4241451, 4241301, 4241391, 4241411, 514885
Abstract:
Methods of treating or preventing an IL-1 related disease or condition in a mammal comprising administering an effective amount of an IL-1β binding antibody or IL-1β binding fragment thereof. An IL-1β binding antibody or IL-1β binding fragment thereof is provided comprising the amino acid sequence of SEQ ID NO: 15 and SEQ ID NO: 11, and related nucleic acids, vectors, cells, and compositions, and a method of preparing an affinity matured IL-1β binding polypeptide. IL-1β binding antibodies or IL-1β binding fragments thereof are provided which have desirable affinity and potency.
Singapore San Diego, CA Rochester, NY Hefei, Anhui, P.R. China Dongyang, Zhejiang, P.R. China Berkeley, CA Hangzhou, Zhejiang, P.R. China Jinhua, Zhejiang, P.R. China
Work:
Nanyang Technological University - Assistant Professor (2010)
Education:
Univ of Rochester, USTC, UC Berkeley, Dongyang Middle School, The Scripps Research Institute
About:
Dr. Gang CHEN received his B.S. degree in Chemistry at the University of Science and Technology of China (USTC) in 2001. He did his Ph.D. studies with Prof. Douglas Turner in the Department of Chemist...